BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18378887)

  • 1. Intermittent prednisolone and autoantibodies to GAD65 in juvenile neuronal ceroid lipofuscinosis.
    Aberg L; Talling M; Härkönen T; Lönnqvist T; Knip M; Alen R; Rantala H; Tyynelä J
    Neurology; 2008 Apr; 70(14):1218-20. PubMed ID: 18378887
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinct patterns of serum immunoreactivity as evidence for multiple brain-directed autoantibodies in juvenile neuronal ceroid lipofuscinosis.
    Lim MJ; Beake J; Bible E; Curran TM; Ramirez-Montealegre D; Pearce DA; Cooper JD
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):469-82. PubMed ID: 16972881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes.
    Striano P; Perruolo G; Errichiello L; Formisano P; Beguinot F; Zara F; Striano S
    Ann Neurol; 2008 Jan; 63(1):127-8. PubMed ID: 17167787
    [No Abstract]   [Full Text] [Related]  

  • 4. An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses.
    Chattopadhyay S; Kriscenski-Perry E; Wenger DA; Pearce DA
    Neurology; 2002 Dec; 59(11):1816-7. PubMed ID: 12473787
    [No Abstract]   [Full Text] [Related]  

  • 5. IgG entry and deposition are components of the neuroimmune response in Batten disease.
    Lim MJ; Alexander N; Benedict JW; Chattopadhyay S; Shemilt SJ; Guérin CJ; Cooper JD; Pearce DA
    Neurobiol Dis; 2007 Feb; 25(2):239-51. PubMed ID: 17070688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered elemental profiles in neuronal ceroid lipofuscinosis.
    Johansson E; Lindh U; Westermarck T; Heiskala H; Santavuori P
    J Trace Elem Electrolytes Health Dis; 1990 Sep; 4(3):139-42. PubMed ID: 2136129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-phenotype correlation in stiff-person syndrome.
    Evoli A
    Neurology; 2008 Dec; 71(24):1938-9. PubMed ID: 18971446
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ceroid lipofuscinosis].
    Zweije-Hofman IL
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):177-81. PubMed ID: 2815054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders.
    Pearce DA; Atkinson M; Tagle DA
    Neurology; 2004 Dec; 63(11):2001-5. PubMed ID: 15596740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment.
    Nociti V; Frisullo G; Tartaglione T; Patanella AK; Iorio R; Tonali PA; Batocchi AP
    Eur J Neurol; 2010 Jan; 17(1):e5. PubMed ID: 19906270
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations in institutionalized neuronal ceroid-lipofuscinosis patients with special reference to involuntary movements.
    Hofman IL
    J Inherit Metab Dis; 1993; 16(2):249-51. PubMed ID: 8411972
    [No Abstract]   [Full Text] [Related]  

  • 13. High levels of Anti-GAD65 and Anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance.
    Ching KH; Burbelo PD; Carlson PJ; Drevets WC; Iadarola MJ
    J Neuroimmunol; 2010 May; 222(1-2):87-9. PubMed ID: 20227114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low erythrocyte plasmalogen and plasma docosahexaenoic acid (DHA) in juvenile neuronal ceroid-lipofuscinosis (JNCL).
    Kohlschütter A; Schade B; Blömer B; Hübner C
    J Inherit Metab Dis; 1993; 16(2):299-304. PubMed ID: 8411986
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimized synthesis of AMPA receptor antagonist ZK 187638 and neurobehavioral activity in a mouse model of neuronal ceroid lipofuscinosis.
    Elger B; Schneider M; Winter E; Carvelli L; Bonomi M; Fracasso C; Guiso G; Colovic M; Caccia S; Mennini T
    ChemMedChem; 2006 Oct; 1(10):1142-8. PubMed ID: 16972289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant therapy in neuronal ceroid-lipofuscinosis.
    Santavuori P; Westermarck T
    Med Biol; 1984; 62(2):152-3. PubMed ID: 6471935
    [No Abstract]   [Full Text] [Related]  

  • 17. Stiff eyes in stiff-person syndrome.
    Oskarsson B; Pelak V; Quan D; Hall D; Foster C; Galetta S
    Neurology; 2008 Jul; 71(5):378-80. PubMed ID: 18663186
    [No Abstract]   [Full Text] [Related]  

  • 18. Electroencephalography in autosomal dominant adult neuronal ceroid lipofuscinosis.
    Nijssen PC; Brekelmans GJ; Roos RA
    Clin Neurophysiol; 2009 Oct; 120(10):1782-6. PubMed ID: 19699676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles of antioxidant therapy in neuronal ceroid lipofuscinosis.
    Westermarck T; Santavuori P
    Med Biol; 1984; 62(2):148-51. PubMed ID: 6471934
    [No Abstract]   [Full Text] [Related]  

  • 20. Late-infantile neuronal ceroid lipofuscinosis (CLN2/Jansky-Bielschowsky type) in Oman.
    Koul R; Al-Futaisi A; Ganesh A; Rangnath Bushnarmuth S
    J Child Neurol; 2007 May; 22(5):555-9. PubMed ID: 17690061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.